Canine Comparative Oncology and Genomics Consortium and the Pfizer-CCOGC Biospecimen Repository Announces the ACCELERATED DISTRIBUTION of Biospecimen Samples
Canine Comparative Oncology and Genomics Consortium and the Pfizer-CCOGC Biospecimen Repository Announces the Sale of 1000 Biospecimens in First Year and Completion of Quality Control and Assessment of Repository
Canine Cancer Samples
Canine Comparative Oncology and Genomics Consortium and the Pfizer-CCOGC Biospecimen Repository Announce the Availability of Canine Cancer Patient Biospecimens for Scientific Study Effective October 29th 2012
Rockville, MD – Canine cancer patient biospecimens are now available for scientific use through the Canine Comparative Oncology and Genomics Consortium (CCOGC) and the Pfizer-CCOGC Biospecimen Repository. The CCOGC has created an infrastructure for the collection and banking of tissues from dogs with naturally occurring cancer to help researchers further the investigation into the inner workings of cancer in the domestic dog, as well as facilitate investigation into tumor types with broad translational relevance that can benefit both human and dog patients. The Pfizer-CCOGC Biospecimen Repository currently houses over 2,000 patient samples across seven spontaneously arising cancer histologies: osteosarcoma, lymphoma, melanoma, pulmonary tumors, mast cell tumor, soft tissue sarcomas and hemangiosarcoma. Samples available from each patient include: tumor and normal tissues (formalin fixed, snap frozen and OCT), as well as frozen serum, plasma, urine and whole blood (from both EDTA and PaxGene RNA collection tubes). For more information about CCOGC and to apply for samples from the biorepository, please visit www.ccogc.net or contact us at firstname.lastname@example.org CCOGC Background Formed in 2004,
Canine Comparative Oncology and Genomics Consortium And the Pfizer-CCOGC Biospecimen Repository Announce the Availability of Canine Biospecimens for Scientific Study
Biospecimen Repository Open
In 2007 sample collection began at three veterinary institutions, with a focus on collecting three histologies of interest in the field of comparative oncology (osteosarcoma, lymphoma, melanoma). In 2008, four additional collection sites were added plus four additional histologies. In accordance with the initial goals of the CCOGC, the prospective collection of tissues is now available. By making use of the existing CCOCG Biorepository infrastructure, investigators can have biospecimens collected to their specifications for unique research needs.